Company news
Bionano Genomics, Inc. news in 2020
Bionano Genomics, Inc.'s news releases, calls and decks from 2020, newest first.
Bionano Genomics Achieves Key Milestone with Software Update for its Saphyr System that Increases Throughput to 96 Human Genomes Per Week and Adds Saphyr Assure for Monitoring System Health
December 20, 2020
Bionano Genomics Reports Third Quarter 2020 Financial Results and Provides Business Update
November 11, 2020
Bionano Genomics Releases Major Update to Its Suite of Software Tools That Simplifies Clinical Analysis, Reduces Time to Actionable Results and Makes Adoption by Clinical Labs Easier
October 20, 2020
Bionano Genomics Announces Positive Outcome of Its Special Stockholder Meeting
September 29, 2020
Bionano Genomics Announces Continued Expansion of Global Business with Adoption of Saphyr for Next-Generation Cytogenomics in Eastern Europe and Australia
September 28, 2020
Bionano Genomics Expands Its Diagnostic Testing Menu with Launch of Lineagen’s EpiPanelDx PLUS Gene Panel Test that Identifies Genetic Conditions Related to Epilepsy
September 13, 2020
Bionano Genomics Announces Continued Expansion of European Business With Adoption of Saphyr at Three of Europe’s Largest Pediatric Hospitals in Spain, Italy and France
September 9, 2020
Bionano Genomics Announces Adjournment of Special Meeting of Stockholders to September 29, 2020
August 30, 2020
Bionano Genomics Appoints Tech Executive Christopher Stewart as its Chief Financial Officer to Help Manage, Grow and Expand Bionano’s Global Business
August 25, 2020
Bionano Genomics Acquires Diagnostics Services Provider Lineagen, Inc. to Accelerate Clinical Adoption of Saphyr for Digital Cytogenetics
August 23, 2020
Bionano Saphyr Services Offered in CLIA Certified Lab Expands Bionano Genomics’ Clinical Applications
August 19, 2020
Bionano Genomics Appoints Industry Leading Cytogeneticist Dr. Alka Chaubey as the Company’s First Chief Medical Officer to Help Lead the Conversion of Cytogenetics to Digital Cytogenetics with Saphyr
August 17, 2020
Bionano Genomics Announces “At-The-Market” Equity Program
August 16, 2020
Bionano Genomics Reports Second Quarter 2020 Financial Results and Provides Business Update
August 12, 2020
Bionano Genomics to Report Second Quarter 2020 Financial Results and Host a Conference Call and Webcast on August 13
August 6, 2020
Bionano Genomics Solidifies its Entry into Solid Tumor Analysis with Launch of New Kit and Protocol that Significantly Simplify Tissue and Solid Tumor Analysis
July 8, 2020
Bionano Genomics Reports First Quarter 2020 Financial Results and Provides Business Update
June 17, 2020
Bionano Genomics Announces Issuance of US Patent for Combined Nanochannel-Nanopore Device
June 7, 2020
Bionano Genomics to Report First Quarter 2020 Financial Results on June 18, 2020
May 13, 2020
Bionano Genomics announces pricing of $18 million underwritten public offering
April 1, 2020
Three Top European Sites Adopt Bionano Saphyr® for Cancer, Genetics, and Cytogenetic Applications
March 22, 2020
Bionano Genomics Reports Fourth Quarter and Year End 2019 Financial Results and Provides Business Update
March 4, 2020
Bionano Genomics to Report Fourth Quarter and Year End 2019 Financial Results and Host a Conference Call and Webcast on March 5
February 27, 2020
Bionano Genomics Releases Saphyr Updates for Industry-Leading Data Yields that Enable Analysis of Complex Cancer Samples at Unprecedented Depths
February 23, 2020
Bionano Genomics’ Saphyr® System is Adopted by GeneDx for the Clinical Detection of Genetic Variants in Muscular Dystrophies, Developmental and Reproductive Disorders
January 5, 2020
Calls in 2020
Decks in 2020
- Merger or Acquisition (August 2020)
Merger or acquisition · 13 slides · Aug 24, 2020